Pacific Biosciences Of California | PACB - Selling And Administration Expenses


Pacific Biosciences Of California reported $37.24M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 465M 11M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Danaher USD 1.86B 166M Mar/2026
General Electric Aerospace USD 1.08B 496M Mar/2026
Illumina USD 272M 11M Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Standard Biotools USD 21.55M 5.05M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Waters USD 394M 153.99M Mar/2026